| Literature DB >> 30650581 |
Tingting Li1,2,3, Shu Su4, Yong Zhao5,6,7, Runze Deng8,9,10, Mingyue Fan11,12,13, Ruoxi Wang14,15,16, Manoj Sharma17, Huan Zeng18,19,20.
Abstract
Objective viral hepatitis is a big challenge in China. However, few studies have focused on mapping the difficulties from a broader view. This study aimed to identify the barriers to the prevention and control of hepatitis B and hepatitis C in communities from the perspectives of hepatitis patients, residents, and healthcare providers. A total of 26 participants were recruited through purposive sampling. Data were collected by in-depth face-to-face interviews from September 2015 to May 2016 in two communities from Chongqing and Chengdu, China. A thematic framework was applied to analyze the qualitative data from the interviews. The critical factors of barriers to hepatitis prevention and control in the districts included poor cognition of residents regarding hepatitis B and hepatitis C, severe stigma in society, inadequate health education, and the provision of unsatisfactory medical services. Strengthening health education and improving services for treating patients with hepatitis are suggested to make further progress. A substantial gap remains between the need and currently available services for hepatitis patients and residents. Delivering quality prevention and control health services, improving health education, and reducing stigma in society are recommended to improve the prevention and control program for hepatitis B and C in communities.Entities:
Keywords: China; hepatitis B; hepatitis C; qualitative research
Mesh:
Year: 2019 PMID: 30650581 PMCID: PMC6352215 DOI: 10.3390/ijerph16020231
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
The socio-demographic characteristics of the interviewees.
| Interviewee | Age | Sex | Location |
|---|---|---|---|
| Patient-1, Hepatitis C, under treatment | 59 | Male | Chengdu |
| Patient-2, Chronic hepatitis B, under treatment | 49 | Male | Chengdu |
| Patient-3, Chronic hepatitis B, under treatment | 45 | Female | Chengdu |
| Patient-4, Chronic hepatitis B, under treatment | 46 | Male | Chongqing |
| Patient-5, Chronic hepatitis B, under treatment | 62 | Female | Chongqing |
| Resident-1 | 61 | Female | Chengdu |
| Resident-2 | 57 | Female | Chongqing |
| Resident-3 | 62 | Male | Chengdu |
| Resident-4 | 80 | Female | Chongqing |
| Resident-5 | 43 | Female | Chengdu |
| Resident-6 | 56 | Female | Chengdu |
| CHC-1, Community Health Service Center Manager | 33 | Male | Chengdu |
| CHC-2, Community Health Service Center Manager | 48 | Female | Chongqing |
| CHC-3, Community Health Service Center worker | 42 | Female | Chongqing |
| CHC-4, Doctor from community health service center | 27 | Male | Chengdu |
| Community leader-1, Community manager | 38 | Female | Chengdu |
| Community leader-2, Community manager | 54 | Male | Chengdu |
| CDC-1, Infectious Disease Prevention and Control Section | 49 | Female | Chongqing |
| CDC-2, STD/AIDS Prevention and Control Department | 39 | Female | Chongqing |
| CDC-3, Department of Immunization Planning | 37 | Female | Chongqing |
| CDC-4, Infectious Disease Prevention and Control Department | 42 | Male | Chongqing |
| CDC-5, Infectious Disease Prevention and Control Department | 55 | Male | Chengdu |
| CDC-6, Infectious Disease Prevention and Control Department | 38 | Female | Chengdu |
| NGO-1, Community health promotion organization | 54 | Female | Chongqing |
| NGO-2, AIDS prevention and control organization | 50 | Male | Chongqing |
| NGO-3, AIDS prevention and control organization | 37 | Male | Chongqing |
Related quotes in the results section.
| Key points | Quotes |
|---|---|
| Poor awareness and knowledge of HBV and HCV care among participants and strong stigma in the society | |
| Inadequate health education about hepatitis B and C in the community | |
| Low-level services currently provided to treat patients with hepatitis B and C | |
| Strengthen health education | |
| Improve services for treating patients with hepatitis B and C |